Getinge AB (publ) (STO: GETI.B)

Market Cap	46.60B
Revenue (ttm)	33.59B
Net Income (ttm)	1.69B
Shares Out	272.37M
EPS (ttm)	6.21
PE Ratio	27.56
Forward PE	17.27
Dividend	4.40 (2.55%)
Ex-Dividend Date	n/a

Volume	2,440,030
Open	180.50
Previous Close	180.50
Day's Range	171.35 - 180.70
52-Week Range	171.35 - 240.20
Beta	0.47
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 28, 2025

About Getinge AB

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, an...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1904
• Employees: 11,739
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: GETI.B

Financial Performance

In 2023, Getinge AB's revenue was 31.83 billion, an increase of 12.49% compared to the previous year's 28.29 billion. Earnings were 2.41 billion, a decrease of -3.17%.